DHL launches six new pharma-focused air corridors between Europe, the US and Asia
Written by AI from 1 report listed below. Not checked by a person before publication. How we use AI
DHL added six new air corridors linking Europe and the United States with Asian pharmaceutical hubs, including Liège–Shanghai, Brussels–Shanghai, Brussels–Singapore, Cincinnati–Singapore, Cincinnati–Tokyo (Narita) and Cincinnati–Seoul (Incheon).
The new routes give pharmaceutical customers greater routing flexibility, access to temperature‑controlled capacity and more predictable transit times, and build on the Brussels–Cincinnati corridor launched earlier this year with a dedicated 777F painted in DHL Health Logistics livery. DHL said the network will extend to Europe, the Middle East, Asia and Latin America, prioritising India, Singapore, Japan, South Korea, Brazil, the United States, Germany and Ireland, with three Asian markets now served and India and Brazil pending.
The corridors are part of the €2 billion investment DHL Group is allocating to its life‑sciences and healthcare business under its 2030 Strategy.